US 9051342
Pyrazole or triazole compounds and their use for the manufacture of a medicament for treating somatic mutation related diseases
granted A61PA61P1/16A61P11/00
Quick answer
US patent 9051342 (Pyrazole or triazole compounds and their use for the manufacture of a medicament for treating somatic mutation related diseases) held by PTC THERAPEUTICS, INC. expires Mon Jun 04 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- PTC THERAPEUTICS, INC.
- Grant date
- Tue Jun 09 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 04 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 4
- CPC classes
- A61P, A61P1/16, A61P11/00, A61P13/12, A61P19/00